Is Viking Therapeutics Stock Running Out of Steam?

Viking's stock has tripled in less than a year, and its red-hot valuation could have investors thinking twice about buying it today. It's not only Viking's share price that has been falling; volume is down, too Investors could still be waiting a long time for approval of a treatment Meanwhile, many top healthcare companies are developing weight loss drugs of their own to try to grab a piece of the lucrative anti-obesity market, which could grow to be worth $100 billion by 2030, according to estimates from G ...